Abcellera Biologics Inc (ABCL) earnings · rev $75.1M
These earnings events as JSON? API free 100/dayAbcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
This ABCL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABCL revenue for 2025-12-31 was $75.1M. Net income was -$146.4M. Revenue was up 160.6% from 2024-12-31 to 2025-12-31. ABCL currently screens at market cap $1.12B.
When the next ABCL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 160.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ABCL research stays on the stock page; the tape stays on the quote page.
ABCL earnings FAQ
What are ABCL's latest revenue and net income?
Latest cached Abcellera Biologics Inc (ABCL) revenue for Dec 31, 2025 was $75.1M. Net income was -$146.4M. Statements: https://lician.com/financials/abcl
What is ABCL's latest diluted EPS?
Latest cached Abcellera Biologics Inc (ABCL) diluted EPS for Dec 31, 2025 was -$0.49.
What period does the latest ABCL earnings print cover?
The latest cached Abcellera Biologics Inc (ABCL) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ABCL revenue change from the prior cached period?
Cached Abcellera Biologics Inc (ABCL) revenue was up 160.6% from $28.8M (Dec 31, 2024) to $75.1M (Dec 31, 2025). Statements: https://lician.com/financials/abcl
Where are ABCL earnings listed?
Cached earnings facts for Abcellera Biologics Inc (ABCL) are listed at https://lician.com/earnings/abcl. Statements: https://lician.com/financials/abcl
Not investment advice.